BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11375214)

  • 1. Preventing exacerbations of chronic bronchitis and COPD.
    Ekberg-Jansson A; Larsson S; Löfdahl CG
    BMJ; 2001 May; 322(7297):1259-61. PubMed ID: 11375214
    [No Abstract]   [Full Text] [Related]  

  • 2. [Usefulness of mucoactive drugs in respiratory diseases].
    Serrano J; Sanchis J
    Arch Bronconeumol; 1998 Jan; 34(1):28-35. PubMed ID: 9522017
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antioxidative features of ambroxol--usefulness in COPD].
    Nowak D
    Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review.
    Poole PJ; Black PN
    BMJ; 2001 May; 322(7297):1271-4. PubMed ID: 11375228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of N-acetylcysteine in the treatment of chronic obstructive pulmonary disease.
    van Herwaarden CL; Bast A; Dekhuijzen PN
    Neth J Med; 1995 Aug; 47(2):45-8. PubMed ID: 7566280
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
    COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation pathway and exacerbations in COPD: the role of NAC.
    Matera MG; Calzetta L; Cazzola M
    Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exacerbations of chronic bronchitis: focusing management for optimum results.
    Aboussouan LS
    Postgrad Med; 1996 Apr; 99(4):89-90, 95-8, 101-2. PubMed ID: 8604417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of ambroxol in chronic bronchitis.
    Guyatt GH; Townsend M; Kazim F; Newhouse MT
    Chest; 1987 Oct; 92(4):618-20. PubMed ID: 3308343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G; Gucci M; Tarò D; Memmini C
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).
    Malerba M; Ponticiello A; Radaeli A; Bensi G; Grassi V
    Pulm Pharmacol Ther; 2004; 17(1):27-34. PubMed ID: 14643168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole PJ; Black PN
    Cochrane Database Syst Rev; 2000; (2):CD001287. PubMed ID: 10796634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [N-acetylcystein in the therapy of chronic bronchitis].
    Reichenberger F; Tamm M
    Pneumologie; 2002 Dec; 56(12):793-7. PubMed ID: 12486618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treating acute exacerbations of chronic bronchitis with N-acetylcysteine?].
    Behr J
    Pneumologie; 2002 Dec; 56(12):768-9. PubMed ID: 12486613
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucolytic and antibiotic effect of a new compound in chronic bronchitis.
    Bŭrgi H
    Chemotherapy; 1975; 21(3-4):167-74. PubMed ID: 1098866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraluminal inflammation in the airways of patients with chronic bronchitis after treatment with Ambroxol.
    Lusuardi M; Capelli A; Salmona M; Tacconi MT; Cerutti CG; Donner CF
    Monaldi Arch Chest Dis; 1995 Oct; 50(5):346-51. PubMed ID: 8541815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis.
    Foxwell AR; Cripps AW; Dear KB
    Cochrane Database Syst Rev; 2003; (3):CD001958. PubMed ID: 12917917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucolytics and antioxidant activity.
    Strapková A; Nosál'ová G; Franová S
    Life Sci; 1999; 65(18-19):1923-5. PubMed ID: 10576438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.